DNA Sequencing In Drug Discovery Market: Emerging Market Trends, Size, Share and Growth Analysis Date: 03-06-2017 09:21 PM CET Category: Health & Medicine Press release from: Transparency Market Research - Biotechnology
DNA sequencing is defined as the process of determining the order of four nucleotide bases i.e. adenine, guanine, cytosine and thymine within the strand of deoxyribonucleic acid (DNA) molecule. DNA sequencing technology is extensively used for drug development since its success in the human genome project, making it an essential tool for genetic analysis. Additionally, innovations in the microarrays, bioinformatics and other important tools have increased the area of application and services of DNA sequencing in drug discovery. On the basis of sequencing tools, DNA sequencing in drug discovery market is fragmented into four major segments namely instruments, consumables, services and workflow. The instruments segment includes: Microarrays - such as biochip microarrays, gel arrays, low and high density microarrays Electrophoresis - majorly involving gel electrophoresis and capillary electrophoresis Polymerase chain reaction (PCR) for DNA amplification Mass spectrometers Microscopes – mostly an electron microscope and an atomic force microscope Micro fluidics-enabled workstations Centrifuge Chromatography equipment Thermal cyclers Charge-coupled devices (CCDs) Browse Global Strategic Business Report: www.transparencymarketresearch.com/dna-sequencing-drug-di... The market for DNA sequencing in drug discovery can also be analyzed on the basis of consumables used during the procedure. Various types of consumables such as chemicals, reagents and probes, DNA polymerase, primes and automated DNA sequencers are being used in DNA sequencing process. On the basis of services and analysis, DNA sequencing in drug
Seite 1 / 3